Skip to content
DraconiticResearch
Search Sources API
223,421 studies31 sourcesUpdated 54 min ago
Peer-reviewedPublisher termsRSC Medicinal Chemistry

Design, synthesis, and antileishmanial evaluation of linker-diversified trimethoxyphenyl-1,2,4-triazole derivatives as folate pathway inhibitors of Leishmania major

6 affiliations
  1. 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University P.O. Box 33516 Kafrelsheikh Egypt
  2. 2Department of Pharmaceutical Sciences, University of Tennessee Health Science Center (UTHSC) Memphis Tennessee 38103 USA
  3. 3Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University P.O. Box 84428 Riyadh 11671 Saudi Arabia
  4. 4Pharmacy Program, Allied Health Department, College of Health and Sport Sciences, University of Bahrain Salmaniya Bahrain
  5. 5Department of Biology, College of Science, University of Bahrain Kingdom of Bahrain
  6. 6Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University Alexandria Egypt

Related

  1. Latest developments in small molecule inhibitors of cysteine protease B as antileishmanial drugs
    Karla Joane da Silva Menezes, Sonaly Lima Albino, João Vitor Vieira da Silva +8
    Future Medicinal ChemistryPeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
  2. Design, synthesis, and biological evaluation of naphthalimide derivatives as dual monoamine oxidase-B and amyloid-β aggregation inhibitors for Alzheimer's disease.
    Rukshar Praveen, Alessandro Gadaleta, Gabriella La Spada +6
    RSC advancesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Synthesis and biological evaluation of pyridine-based derivatives as potential inhibitors of Leishmania major propagation.
    Ahmed Sabt, Adnan A Bekhit, Hanaa Farag +7
    RSC advancesPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
  4. In silico methods of Molecular Docking, ADMET, DFT and MD simulations reveal the potential of cis-hydroxycinnamic acid derivatives as potent Acetylcholinesterase Inhibitors
    Shabir H. Lone, Basit Qayoom, Waheed Ahmad Khanday +3
    In Silico PharmacologyPeer-reviewedLicence not statedFull textPharmacology & toxicologyPMC
  5. Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
    Tanawan Kongmalai, Natthakan Chitpim, Varalak Srinonprasert +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
BibTeX
@article{elsawi2026design,
  title = {{Design, synthesis, and antileishmanial evaluation of linker-diversified trimethoxyphenyl-1,2,4-triazole derivatives as folate pathway inhibitors of Leishmania major}},
  author = {Ahmed E. Elsawi and Mohamed Abdelfadil and Tarfah Al-Warhi and Sherry N. Nasralla and Salwa Mutlaq Al-Thawadi and Tamer M. Ibrahim and Adnan A. Bekhit and Wagdy M. Eldehna},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  month = oct,
  doi = {10.1039/d6md00548a},
  url = {https://doi.org/10.1039/d6md00548a},
}
RIS
TY  - JOUR
TI  - Design, synthesis, and antileishmanial evaluation of linker-diversified trimethoxyphenyl-1,2,4-triazole derivatives as folate pathway inhibitors of Leishmania major
AU  - Ahmed E. Elsawi
AU  - Mohamed Abdelfadil
AU  - Tarfah Al-Warhi
AU  - Sherry N. Nasralla
AU  - Salwa Mutlaq Al-Thawadi
AU  - Tamer M. Ibrahim
AU  - Adnan A. Bekhit
AU  - Wagdy M. Eldehna
PY  - 2026
DA  - 2026/10/19
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d6md00548a
UR  - https://doi.org/10.1039/d6md00548a
SN  - 2632-8682
ER  -